These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33110240)

  • 1. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets.
    Serebrovska ZO; Chong EY; Serebrovska TV; Tumanovska LV; Xi L
    Acta Pharmacol Sin; 2020 Dec; 41(12):1539-1546. PubMed ID: 33110240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α.
    Moasefi N; Fouladi M; Norooznezhad AH; Yarani R; Rahmani A; Mansouri K
    Inflamm Res; 2021 Jul; 70(7):749-752. PubMed ID: 34173853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.
    Wing PAC; Keeley TP; Zhuang X; Lee JY; Prange-Barczynska M; Tsukuda S; Morgan SB; Harding AC; Argles ILA; Kurlekar S; Noerenberg M; Thompson CP; Huang KA; Balfe P; Watashi K; Castello A; Hinks TSC; James W; Ratcliffe PJ; Davis I; Hodson EJ; Bishop T; McKeating JA
    Cell Rep; 2021 Apr; 35(3):109020. PubMed ID: 33852916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19.
    Tian M; Liu W; Li X; Zhao P; Shereen MA; Zhu C; Huang S; Liu S; Yu X; Yue M; Pan P; Wang W; Li Y; Chen X; Wu K; Luo Z; Zhang Q; Wu J
    Signal Transduct Target Ther; 2021 Aug; 6(1):308. PubMed ID: 34408131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy.
    Zuo X; Ren S; Zhang H; Tian J; Tian R; Han B; Liu H; Dong Q; Wang Z; Cui Y; Niu R; Zhang F
    J Transl Med; 2022 Nov; 20(1):509. PubMed ID: 36335375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model.
    Choi Y; Shin B; Kang K; Park S; Beck BR
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33218024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
    Shawki MA; Elsayed NS; Mantawy EM; Said RS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1 alpha (HIF-1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy.
    Zalpoor H; Akbari A; Nabi-Afjadi M; Forghaniesfidvajani R; Tavakol C; Barzegar Z; Iravanpour F; Hosseini M; Mousavi SR; Farrokhi MR
    Hum Cell; 2022 Sep; 35(5):1338-1345. PubMed ID: 35831562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
    Norooznezhad AH; Mansouri K
    Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Discovery, diagnostics and drug development.
    Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
    J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
    Vlachakis D; Papakonstantinou E; Mitsis T; Pierouli K; Diakou I; Chrousos G; Bacopoulou F
    Food Chem Toxicol; 2020 Dec; 146():111805. PubMed ID: 33038452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Sallenave JM; Guillot L
    Front Immunol; 2020; 11():1229. PubMed ID: 32574272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.
    Peng X; Wang Y; Xi X; Jia Y; Tian J; Yu B; Tian J
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):231-247. PubMed ID: 33404925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
    Zlacká J; Stebelová K; Zeman M; Herichová I
    Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cell receptors: potential drug targets to combat COVID-19.
    Raghav PK; Kalyanaraman K; Kumar D
    Amino Acids; 2021 Jun; 53(6):813-842. PubMed ID: 33950300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.